Vincent Dumont is a cell biologist and pharmacologist with 9 years of experience in academia and 5 years of experience in pharmaceutical industry.

He conducted his PhD studies under the supervision of Pr Sanna Lehtonen at the University of Helsinki, Finland, where he investigated the renal complications of diabetes.

Since 2020, he has been supporting drug discovery programs at Galapagos and Novalix as a pharmacologist and biomarker expert on kidney, oncology and immunology topics.

During his career, he acquired expertise in advanced technologies such as high-resolution microscopy, single-nuclei RNA sequencing or multi-parametric flow cytometry.